Predict your next investment

Venture Capital
biovedavc.com

See what CB Insights has to offer

Investments

24

Portfolio Exits

8

About BioVeda Capital

BioVeda is a Singapore based firm which invests in companies in the healthcare sector with leading market positions, proprietary technologies, and outstanding scientific and management talent.

BioVeda Capital Headquarters Location

50 Cuscaden Road #07-02 HPL House

249724,

Singapore

65-6238-9200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest BioVeda Capital News

Facebook Co-Founder Saverin Backs Health Marketplace Startup CXA

Feb 8, 2017

BioVeda Capital also joined the round. Your cheat sheet on life, in one weekly email. Get our weekly Game Plan newsletter. Sign Up CXA is among a growing crop of startups trying to build an online marketplace for health services, from insurance to data management. Founded by Chief Executive Officer Rosaline Koo, the daughter of an illegal Chinese immigrant who made his way from Mexico to San Francisco by sea, CXA now has annual revenue of S$10 million ($7 million) and counts 45 Fortune 500 companies among its 500 corporate clients, she said. Saverin will join the board of CXA, which plans to expand to 10 countries across Asia in addition to its current markets of Singapore and Hong Kong. Koo, 55, moved to Singapore before starting CXA in 2013 with S$5 million in savings, after a stint overseeing a 14 country-operation for Mercer Marsh Benefits. She grew up in a Los Angeles ghetto during the Watts riots of the 1960s. Like her father, her mother moved to the U.S. from China, leaving two daughters behind when the Communist Party seized her property. A number of venture capital firms and private equity firms had expressed their interest in funding CXA but B Capital and EDBI were picked for this round because of their focus on health and wellness, Koo said. Before it's here, it's on the Bloomberg Terminal.

BioVeda Capital Investments

24 Investments

BioVeda Capital has made 24 investments. Their latest investment was in CXA Group as part of their Series B on February 2, 2017.

CBI Logo

BioVeda Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/7/2017

Series B

CXA Group

$25M

No

4

12/7/2015

Series C

ASLAN Pharmaceuticals

$34M

No

2

4/2/2015

Convertible Note - V

Jaguar Animal Health

$1M

Yes

1

2/10/2015

Series A

Subscribe to see more

$99M

Subscribe to see more

10

6/12/2014

Convertible Note

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/7/2017

12/7/2015

4/2/2015

2/10/2015

6/12/2014

Round

Series B

Series C

Convertible Note - V

Series A

Convertible Note

Company

CXA Group

ASLAN Pharmaceuticals

Jaguar Animal Health

Subscribe to see more

Subscribe to see more

Amount

$25M

$34M

$1M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

2

1

10

10

BioVeda Capital Portfolio Exits

8 Portfolio Exits

BioVeda Capital has 8 portfolio exits. Their latest portfolio exit was Clarus Therapeutics on September 09, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/9/2021

Reverse Merger

$99M

3

5/16/2017

IPO

Subscribe to see more

$99M

Subscribe to see more

10

5/13/2015

IPO

Subscribe to see more

$99M

Subscribe to see more

10

11/26/2008

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

10

5/9/2008

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

0

Date

9/9/2021

5/16/2017

5/13/2015

11/26/2008

5/9/2008

Exit

Reverse Merger

IPO

IPO

Acq - P2P

Acq - P2P

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

0

BioVeda Capital Acquisitions

1 Acquisition

BioVeda Capital acquired 1 company. Their latest acquisition was Nexchem on December 08, 2009.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/8/2009

$99M

Acq - Fin

1

Date

12/8/2009

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acq - Fin

Sources

1

BioVeda Capital Team

4 Team Members

BioVeda Capital has 4 team members, including current General Partner, Juanita Fu.

Name

Work History

Title

Status

Juanita Fu

General Partner

Current

Kho Choon Joo

General Partner

Current

Kho C Koo

General Partner

Current

Damien Lim

PrimePartners Corporate Finance Holdings, and Morgan Grenfell Private Equity

General Partner

Current

Name

Juanita Fu

Kho Choon Joo

Kho C Koo

Damien Lim

Work History

PrimePartners Corporate Finance Holdings, and Morgan Grenfell Private Equity

Title

General Partner

General Partner

General Partner

General Partner

Status

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.